Jami Rubin
Patrimonio netto: 1 M $ in data 31/08/2026
Patrimonio netto: 1 M $ in data 31/08/2026
Jami Rubin currently works at Gilda's Club New York City, Inc., as Director from 2010.
Ms. Rubin also formerly worked at Relay Therapeutics, Inc., as Independent Director from 2019 to 2025, Salomon Smith Barney, Inc., as Managing Director, EQRx, Inc., as Chief Financial & Accounting Officer from 2021 to 2023, Nomura Securities International, Inc., as Principal in 1994, PJT Partners, Inc., as Partner from 2019 to 2021, Morgan Stanley & Co. LLC, as Research Analyst, Goldman Sachs & Co. LLC, as Analyst from 2008 to 2018, Kidder, Peabody & Co., Inc., as Principal in 1995, Boundless Bio, Inc., as Chief Financial Officer & Treasurer from 2023 to 2024, and ARCH Venture Partners LLC, as Venture Partner from 2023 to 2025.
Ms. Rubin received her undergraduate degree in 1985 from Vassar College.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 06/06/2025 | 67.242 ( 0,03% ) | 1 M $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
Gilda's Club New York City, Inc.
Gilda's Club New York City, Inc. Miscellaneous Commercial ServicesCommercial Services Provides support services to cancer patients | Direttore/Membro del Consiglio | 01/01/2010 |
| Società | Posizione | Fine |
|---|---|---|
| RELAY THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 08/06/2025 |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Investitore di Private Equity | 01/01/2025 |
| BOUNDLESS BIO, INC. | Direttore Finanziario/CFO | 11/10/2024 |
| EQRX, INC. | Direttore Finanziario/CFO | 31/03/2023 |
| PJT PARTNERS INC. | Corporate Officer/Principal | 01/04/2021 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 12 |
|---|---|
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
PJT Partners, Inc.
PJT Partners, Inc. Investment Banks/BrokersFinance Operates as a holding company that engages in the provision of financial advisory services | Finance |
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Nomura Securities International, Inc.
Nomura Securities International, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Vassar College
Vassar College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kidder, Peabody & Co., Inc.
Kidder, Peabody & Co., Inc. Regional BanksFinance Provides investment banking services | Finance |
Salomon Smith Barney, Inc.
Salomon Smith Barney, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Gilda's Club New York City, Inc.
Gilda's Club New York City, Inc. Miscellaneous Commercial ServicesCommercial Services Provides support services to cancer patients | Commercial Services |
Relay Therapeutics, Inc.
Relay Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage precision medicine company, which focus on enhancing small molecule therapeutic discovery in targeted oncology | Health Technology |
Boundless Bio, Inc.
Boundless Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that develops cancer therapeutics | Health Technology |
EQRx, Inc.
EQRx, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers medicines for lung cancer | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale